Skip to main content
logo
Entrada Therapeutics logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
4.780
+0.230 (5.05%)
At close: Oct 15, 2026, 4:00 PM EDT
4.770
-0.010 (-0.21%)
After-hours: Oct 15, 2026, 7:30 PM EDT

Entrada Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-165.78-143.7565.63-6.69-94.62-51.16
Depreciation & Amortization
3.764.13.772.841.91.12
Loss (Gain) From Sale of Assets
-----0.07
Loss (Gain) From Sale of Investments
-2.37-3.67-10.02-5.780.15-
Stock-Based Compensation
19.3719.6117.9213.119.92.53
Change in Accounts Receivable
0.362.52.2-5.88--
Change in Accounts Payable
1.89-1.80.99-2.815.29-0.72
Change in Unearned Revenue
-0.71-19.83-119.81139.98--
Change in Income Taxes
--0.67-3.364.02--
Change in Other Net Operating Assets
8.814.991.121-16.4-2.71
Operating Cash Flow
-134.67-128.51-41.56139.8-93.79-50.86
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
0.32-1.04-3.16-5.61-2.89-4.58
Investment in Securities
159.84117.85-24.64-132.78-145.76-
Investing Cash Flow
160.16116.81-27.8-138.4-148.65-4.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
0.650.89102.9621.040.48191.63
Financing Cash Flow
0.650.89102.9621.040.48307.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
26.14-10.8233.6122.45-241.96252.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-134.35-129.55-44.72134.19-96.67-55.44
Free Cash Flow Growth
------
Free Cash Flow Margin
-2867.07%-509.63%-21.21%104.01%--
Free Cash Flow Per Share
-3.21-3.13-1.154.06-3.09-8.85
Levered Free Cash Flow
-77.67-76.96-73.29149.04-58.56-36.26
Unlevered Free Cash Flow
-77.67-76.96-73.29149.04-58.56-36.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1.71.74.6214.72--
Change in Working Capital
10.34-4.8-118.85136.32-11.11-3.42
SEC Filings: 10-K · 10-Q